Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes

NCT01159288 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: Dex2

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris